Navigation Links
Federal DePuy ASR Litigation Schedules July Conference to Discuss Lawsuits over Recalled Hip Replacement

(PRWEB) July 19, 2014

A federal litigation that now includes more than 8,600 DePuy ASR hip lawsuits ( has scheduled a meeting to discuss issues pertaining to claims involving the recalled metal-on-metal hip replacement, Bernstein Liebhard LLP reports.

According to documents updated this week, a status conference in the U.S. District Court, Northern District of Ohio has been scheduled to take place on July 18, 2014 at 9:30 a.m. Parties involved in the litigation will address a Progress Report on the MDL by the leadership, an oral argument on pending motions in several lawsuits over the DePuy ASR Hip Replacement System, and matters related to a DePuy settlement agreement proposed last year, court records indicate. (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation – MDL 2197)

“As our Firm continues to represent numerous individuals in the DePuy ASR recall litigation, we are pleased to see the proceeding moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free and confidential case evaluations to individuals who allegedly suffered chronic pain, premature hip failure, symptoms associated with metallosis and other complications associated with the DePuy ASR recall.

DePuy ASR Litigation
Court documents indicate that cases in the DePuy ASR hip litigation are continuing to move forward in the Northern District of Ohio. According to a Case List updated on July 15th, a total of 8,656 lawsuits have now been filed in the federal litigation by plaintiffs who were allegedly injured by the metal-on-metal hip replacement. Court records indicate that Plaintiffs in these cases similarly allege that the Johnson & Johnson subsidiary, DePuy Orthopaedics defectively designed a product that, because of its all-metal design, may shred dangerous amounts of toxic metal debris into the blood stream. These individuals were implanted with the ASR metal-on-metal hip replacement prior to its recall in August 2010.

In November 2013, Johnson & Johnson and DePuy proposed an ASR settlement that would resolve some 8,000 claims filed in the wake of the recall. According to court documents, the agreement stipulates that only individuals who underwent an ASR revision surgery prior to August 31, 2013 would be eligible to participate, and receive a base award of $250,000. Other factors, including prior medical history and the number of revision surgeries undergone by each plaintiff, could affect the award amount. DePuy ASR lawsuit plaintiffs who are either not eligible, or wish not to participate in the settlement may pursue individual claims against Johnson & Johnson and DePuy.

Individuals who were allegedly harmed by a DePuy ASR hip implant may be entitled to compensation for medical bills, lost wages, pain and suffering, and more. Learn more about filing a DePuy ASR lawsuit, please visit Bernstein Liebhard LLP’s website. For a free, no obligation case review, please call the Firm directly at 800-511-5092.

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Read the full story at

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. MCG/VA psychology training program gets federal funding for fifth consecutive time
2. Federal Judge Overseeing Ethicon Vaginal Mesh Lawsuit Denies Summary Judgment on Certain Claims, Bernstein Liebhard LLP Reports
3. Transvaginal Mesh Lawsuit News: Federal Plaintiff Allowed to Pursue Claims Related to Use of Prolene in Ethicon Mesh Products, Bernstein Liebhard LLP Reports
4. Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports
5. Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports
6. Federal funding cliff could cause health safety net clinics to shrink by one-quarter
7. GranuFlo Lawsuits News: Missouri Federal Court Returns Multi-Plaintiff Case to State Court, Rottenstein Law Group LLP Reports
8. Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of New Order in Federal C.R. Bard Litigation
9. Pradaxa Lawsuits Move Forward, as Federal Litigation Schedules January Status Conference, Bernstein Liebhard LLP Reports
10. Fosamax Lawsuits: Bellwether Trials Scheduled in Federal, State Fosamax Femur Fracture Litigations, Bernstein Liebhard LLP Reports
11. Transvaginal Mesh Lawsuit News: Bellwether Trial in Federal C.R. Bard Vaginal Mesh Litigation Postponed, Bernstein Liebhard LLP Reports
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... "When I underwent ... bras were incredibly uncomfortable," said an inventor from Bronx, N.Y. "In order to ... the patent-pending RECOVERY BRA for added comfort and support. The bra is easier ...
(Date:11/25/2015)... ... November 25, 2015 , ... Bcureful—a non-profit organization devoted to ... raising public awareness of the disorder while helping to bring expert medical care ... to bolster progress at the Tuberous Sclerosis Complex Center at Ann & Robert ...
(Date:11/24/2015)... Florida (PRWEB) , ... November 25, 2015 , ... ... planning and monitoring. Their Care Plan software creates an agreement between the ... patient care plan, including financial, scheduling, monitoring, notification, and projections. Click ...
(Date:11/24/2015)... ... November 24, 2015 , ... Young patients with a ... Dr. Angela Wolfman and Dr. Kedar S. Lele, who are pediatric dentists in ... and fillings, the WaterLase iPlus 2.0™ system causes minimal discomfort and bleeding to the ...
(Date:11/24/2015)... ... November 25, 2015 , ... ... solutions for drugs, biologics, consumer health and global clinical supply services, today announced ... upcoming Clinical Trial Supply East Asia Conference, to be held at the InterContinental ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... Nov. 24, 2015  Thanks to a donor with ... Mary,s Medical Center,s Sister Diane Grassilli Center for Women,s ... in San Francisco . ... stepped forward with a gift of $617,320 that allowed ... Mammography with Tomosynthesis and Whole Breast Ultrasound. Tomosynthesis, three-dimensional ...
(Date:11/24/2015)... 24, 2015  Array BioPharma Inc. (Nasdaq: ... Officer, Ron Squarer , will present at ... York.  The public is welcome to participate in ... BioPharma website.Event:Piper Jaffray Annual Healthcare ConferencePresenter:  , Ron ... 2015Time:1:30 p.m. Eastern Time Webcast: , ...
(Date:11/24/2015)... and VANCOUVER, Nov. 24, 2015 /PRNewswire/ - ESSA ... EPIX ) announced today that the first patient ... of EPI-506 as a treatment for metastatic castration-resistant prostate ... and Canada.  --> the ... In the Phase 1/2 clinical trial, ESSA intends ...
Breaking Medicine Technology: